However, the underlying pathogenic mechanism linking elevated circulating levels of ITGA1 to adverse left ventricular remodelling and functional impairment in individuals with type 2 diabetes remains unclear. The gene discussed is ITGA1; the disease is type 2 diabetes mellitus.